{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:21:01Z","timestamp":1719879661712},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.7759\/cureus.63613","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T21:13:55Z","timestamp":1719868435000},"source":"Crossref","is-referenced-by-count":0,"title":["Invasive Mycobacterium bovis Infection Outside the Genitourinary Tract Following Bacille Calmette-Guerin Therapy for Non-muscle Invasive Bladder Cancer"],"prefix":"10.7759","author":[{"given":"Debduti","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Booth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher","family":"Sbitli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin T","family":"Shiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Pomakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00744-3","article-title":"Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice","volume":"20","author":"van Hoogstraten LM","year":"2023","unstructured":"van Hoogstraten LM, Vrieling A, van der Heijden AG, Kogevinas M, Richters A, Kiemeney LA. Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nat Rev Clin Oncol. 2023, 20:287-304. 10.1038\/s41571-023-00744-3","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-534764273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester R","year":"2002","unstructured":"Sylvester R, Meijden A, Lamm D. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002, 168:1964-70. 10.1016\/S0022-534764273-5","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071366","article-title":"Revolutionizing treatment: breakthrough approaches for BCG-unresponsive non-muscle-invasive bladder cancer","volume":"16","author":"Jaromin M","year":"2024","unstructured":"Jaromin M, Konecki T, Kutwin P. Revolutionizing treatment: breakthrough approaches for BCG-unresponsive non-muscle-invasive bladder cancer. Cancers (Basel). 2024, 16:10.3390\/cancers16071366","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)55282","article-title":"Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer","volume":"124","author":"Lamm DL","year":"1980","unstructured":"Lamm DL, Thor DE, Harris SC, et al.. Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer. J Urol. 1980, 124:38-40. 10.1016\/s0022-5347(17)55282","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2024","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) prostato-epididymitis in a patient treated for a non-invasive urothelial cancer: a case report","volume":"36","author":"Salif A","year":"2024","unstructured":"Salif A, Bigirimana F, Willems S, et al.. Bacillus Calmette-Gu\u00e9rin (BCG) prostato-epididymitis in a patient treated for a non-invasive urothelial cancer: a case report. IDCases. 2024, 36:e01967. 10.1016\/j.idcr.2024","journal-title":"IDCases"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2022.2118606","article-title":"Immunotherapy for bladder cancer: latest advances and ongoing clinical trials","volume":"51","author":"Ward Grados DF","year":"2022","unstructured":"Ward Grados DF, Ahmadi H, Griffith TS, Warlick CA. Immunotherapy for bladder cancer: latest advances and ongoing clinical trials. Immunol Invest. 2022, 51:2226-51. 10.1080\/08820139.2022.2118606","journal-title":"Immunol Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pulmoe.2019.10","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review","volume":"26","author":"Marques M","year":"2020","unstructured":"Marques M, Vazquez D, Sousa S, Mesquita G, Duarte M, Ferreira R. Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection with pulmonary and renal involvement: a rare complication of BCG immunotherapy. A case report and narrative review. Pulmonology. 2020, 26:346-52. 10.1016\/j.pulmoe.2019.10","journal-title":"Pulmonology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bju.15608","article-title":"Incidence of and mortality from Bacille Calmette-Gu\u00e9rin (BCG) infections after BCG instillation therapy","volume":"129","author":"Nurminen P","year":"2022","unstructured":"Nurminen P, Ettala O, Uusitalo-Sepp\u00e4l\u00e4 R, Nummi A, J\u00e4rvinen R, Antti K, Bostr\u00f6m PJ. Incidence of and mortality from Bacille Calmette-Gu\u00e9rin (BCG) infections after BCG instillation therapy. BJU Int. 2022, 129:737-43. 10.1111\/bju.15608","journal-title":"BJU Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.11","article-title":"BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: a systematic review","volume":"39","author":"Cabas P","year":"2021","unstructured":"Cabas P, Rizzo M, Giuffr\u00e8 M, et al.. BCG infection (BCGitis) following intravesical instillation for bladder cancer and time interval between treatment and presentation: a systematic review. Urologic oncology. 2021, 39:85-92. 10.1016\/j.urolonc.2020.11","journal-title":"Urologic oncology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1067\/mva.1988.avs0070808","article-title":"Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Gu\u00e9rin vaccine for malignancy","volume":"7","author":"Woods JM 4th","year":"1988","unstructured":"Woods JM 4th, Schellack J, Stewart MT, Murray DR, Schwartzman SW. Mycotic abdominal aortic aneurysm induced by immunotherapy with bacille Calmette-Gu\u00e9rin vaccine for malignancy. J Vasc Surg. 1988, 7:808-10. 10.1067\/mva.1988.avs0070808","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2022.04","article-title":"Mycotic arterial aneurysm secondary to BCG intravesical instillation: a review","volume":"vol. 47","author":"Palmier M","year":"2022","unstructured":"Palmier M, Monnot A, Teni\u00e8re T, Cohen Q, Plissonnier D. Mycotic arterial aneurysm secondary to BCG intravesical instillation: a review. J Med Vasc. 2022, vol. 47:94-105. 10.1016\/j.jdmv.2022.04","journal-title":"J Med Vasc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2013.11.002","article-title":"Mycotic aortic aneurysm due to intravesical BCG immunotherapy: clinical manifestations and diagnostic challenges","volume":"3","author":"Holmes BJ","year":"2014","unstructured":"Holmes BJ, LaRue RW, Black JH 3rd, Dionne K, Parrish NM, Melia MT. Mycotic aortic aneurysm due to intravesical BCG immunotherapy: clinical manifestations and diagnostic challenges. Int J Mycobacteriol. 2014, 3:60-5. 10.1016\/j.ijmyco.2013.11.002","journal-title":"Int J Mycobacteriol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvscit.2023.101213","article-title":"A case of mycotic infrarenal abdominal aortic aneurysm after bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer and a review of the literature","volume":"9","author":"Satchithanantham V","year":"2023","unstructured":"Satchithanantham V, Babiker T, Riding G, Banihani M. A case of mycotic infrarenal abdominal aortic aneurysm after bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer and a review of the literature. J Vasc Surg Cases Innov Tech. 2023, 9:101213. 10.1016\/j.jvscit.2023.101213","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)35824-x","article-title":"Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin","volume":"150","author":"Izes JK","year":"1993","unstructured":"Izes JK, Bihrle W 3rd, Thomas CB. Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin. J Urol. 1993, 150:1498-500. 10.1016\/s0022-5347(17)35824-x","journal-title":"J Urol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2023.101902","article-title":"A case of disseminated M. bovis bacillus Calmette-Gu\u00e9rin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017-2022","volume":"45","author":"Nishimura M","year":"2023","unstructured":"Nishimura M, Okumura M, Takemasa T, Yoshiyama T, Tanaka Y, Saotome M, Ohta K. A case of disseminated M. bovis bacillus Calmette-Gu\u00e9rin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017-2022. Respir Med Case Rep. 2023, 45:101902. 10.1016\/j.rmcr.2023.101902","journal-title":"Respir Med Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab033","article-title":"Disseminated BCG infection after intravesical BCG immunotherapy of bladder cancer","volume":"114","author":"Ramalingam S","year":"2021","unstructured":"Ramalingam S, Gunasekaran K, Arora H, Muruganandam M, Nagaraju S, Padmanabhan P. Disseminated BCG infection after intravesical BCG immunotherapy of bladder cancer. QJM. 2021, 114:410-11. 10.1093\/qjmed\/hcab033","journal-title":"QJM"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq002","article-title":"Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin used for immunotherapy in bladder cancer","volume":"52","author":"Watts MR","year":"2011","unstructured":"Watts MR, Taylor PC, Sintchenko V, et al.. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin used for immunotherapy in bladder cancer. Clin Infect Dis. 2011, 52:86-8. 10.1093\/cid\/ciq002","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1086\/344908","article-title":"Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez OY","year":"2003","unstructured":"Gonzalez OY, Musher DM, Brar I, et al.. Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy. Clin Infect Dis. 2003, 36:140-8. 10.1086\/344908","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/265294-invasive-mycobacterium-bovis-infection-outside-the-genitourinary-tract-following-bacille-calmette-guerin-therapy-for-non-muscle-invasive-bladder-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T21:13:58Z","timestamp":1719868438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/265294-invasive-mycobacterium-bovis-infection-outside-the-genitourinary-tract-following-bacille-calmette-guerin-therapy-for-non-muscle-invasive-bladder-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.63613","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}